Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The Global mRNA Vaccines & Therapeutics market was valued at XX.0 million US$ in 2018, with the CAGR of 6.4%, this market is estimated to reach USD XX.0 million US$ in 2026.
This report mainly elaborates on the segmentation, end-user, size, share, trend, future demand and leading players with respect to the Global and Europe mRNA Vaccines & Therapeutics market. Describe product range of mRNA Vaccines & Therapeutics, market overview, market opportunities, market drivers, limitations, PEST and SWOT analysis. Introducing market share, production, consumption, revenue, and growth of Global major regions from 2014-2019 and forecast to 2026.
The report also provides a detailed analysis of the Europe mRNA Vaccines & Therapeutics market from 2014 to 2026 based on the product type and end-user. It provides a detailed overview of the market of the top 16 countries of Europe along with top companies' data analysis and product introductions of Europe mRNA Vaccines & Therapeutics market.
By Player
PhaseRx
MaxCyte
CureVac
AstraZeneca
Bayer
BioNTech
RaNa Therapeutics
Moderna Therapeutics
Precision NanoSystems
Argos Therapeutics
Novartis
GlaxoSmithKline Vaccines
Kernal Biologics
In-Cell-Art
Janssen
Intellia Therapeutics
CRISPR Therapeutics
eTheRNA immunotherapies
Boehringer Ingelheim
Ethris
By Type
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
By End-User
Hospital
Clinic
Others
By Region
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Belgium
-
Poland
-
Russia
-
Turkey
-
Netherlands
-
Portugal
-
Denmark
-
Finland
-
Iceland
-
Norway
-
Sweden
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Australia and New Zealand
-
ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)
Latin America, Middle East & Africa
-
GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)
-
Brazil
-
Nigeria
-
South Africa
-
Argentina
-
Others
Table of Contents
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of mRNA Vaccines & Therapeutics Market
-
1.3 Market Segment by Type
-
1.3.1 Global mRNA Vaccines & Therapeutics Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine from 2014 to 2026
-
1.3.2 Global mRNA Vaccines & Therapeutics Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine from 2014 to 2026
-
1.3.3 Global mRNA Vaccines & Therapeutics Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine from 2014 to 2026
-
1.3.4 Global mRNA Vaccines & Therapeutics Market Size and Growth Rate of Infection Prevention MRNA Vaccine from 2014 to 2026
-
1.4 Market Segment by Application
-
1.4.1 Global mRNA Vaccines & Therapeutics Market Size and Growth Rate of Hospital from 2014 to 2026
-
1.4.2 Global mRNA Vaccines & Therapeutics Market Size and Growth Rate of Clinic from 2014 to 2026
-
1.4.3 Global mRNA Vaccines & Therapeutics Market Size and Growth Rate of Others from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 North America mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Europe mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Asia-Pacific mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 LAMEA mRNA Vaccines & Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of mRNA Vaccines & Therapeutics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of mRNA Vaccines & Therapeutics by Major Types
-
3.4.1 mRNA Vaccines & Therapeutics Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine
-
3.4.2 mRNA Vaccines & Therapeutics Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine
-
3.4.3 mRNA Vaccines & Therapeutics Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine
-
3.4.4 mRNA Vaccines & Therapeutics Market Size and Growth Rate of Infection Prevention MRNA Vaccine
4 Segmentation of mRNA Vaccines & Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of mRNA Vaccines & Therapeutics by Major End-Users
-
4.4.1 Market Size and Growth Rate of mRNA Vaccines & Therapeutics for Hospital
-
4.4.2 Market Size and Growth Rate of mRNA Vaccines & Therapeutics for Clinic
-
4.4.3 Market Size and Growth Rate of mRNA Vaccines & Therapeutics for Others
5 Market Analysis by Major Regions
-
5.1 Global mRNA Vaccines & Therapeutics Production Analysis by Top Regions
-
5.2 Global mRNA Vaccines & Therapeutics Consumption Analysis by Top Regions
-
5.3 Global mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis by Regions
-
5.3.1 North America mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis
-
5.3.2 Europe mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis
-
5.3.3 Asia Pacific mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis
-
5.3.4 LAMEA mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis
6 Product Circulation of mRNA Vaccines & Therapeutics Market among Top Countries
-
6.1 Top 5 Export Countries in mRNA Vaccines & Therapeutics Market from 2014 to 2019
-
6.1.1 Top 5 Export Countries’ Export Value Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019
-
6.1.2 Top 5 Export Countries’ Export Volume Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019
-
6.2 Top 5 Import Countries in mRNA Vaccines & Therapeutics Market from 2014 to 2019
-
6.2.1 Top 5 Import Countries’ Import Value Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019
-
6.2.2 Top 5 Import Countries’ Import Volume Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019
-
6.3 Emerging Top 3 Export Countries Analysis
-
6.4 Emerging Top 3 Import Countries Analysis
7. North America mRNA Vaccines & Therapeutics Landscape Analysis
-
7.1 North America mRNA Vaccines & Therapeutics Landscape Analysis by Top Countries
-
7.1.1 United States mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
7.1.2 Canada mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
7.1.3 Mexico mRNA Vaccines & Therapeutics Market Volume and Growth Rate
8. Europe mRNA Vaccines & Therapeutics Landscape Analysis
-
8.1 Europe mRNA Vaccines & Therapeutics Landscape Analysis by Major Types
-
8.2 Europe mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users
-
8.3 Europe mRNA Vaccines & Therapeutics Landscape Analysis by Top Countries
-
8.3.1 Germany mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
8.3.2 UK mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
8.3.3 France mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
8.3.4 Italy mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
8.3.5 Spain mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
8.3.6 Belgium mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
8.3.7 Poland mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
8.3.8 Russia mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
8.3.9 Turkey mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
8.3.10 Netherlands mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
8.3.11 Portugal mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
8.3.12 Denmark mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
8.3.13 Finland mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
8.3.14 Iceland mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
8.3.15 Norway mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
8.3.16 Sweden mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
8.4 Top 3 Players Profiles in Europe
9 Asia Pacific mRNA Vaccines & Therapeutics Landscape Analysis
-
9.1 Asia Pacific mRNA Vaccines & Therapeutics Landscape Analysis by Top Countries
-
9.1.1 China mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
9.1.2 Japan mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
9.1.3 Australia and New Zealand (ANZ) mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
9.1.4 India mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
9.1.5 ASEAN mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
9.1.6 South Korea mRNA Vaccines & Therapeutics Market Volume and Growth Rate
10 LAMEA mRNA Vaccines & Therapeutics Landscape Analysis
-
10.1 LAMEA mRNA Vaccines & Therapeutics Landscape Analysis by Top Countries
-
10.1.1 GCC Countries mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
10.1.2 Brazil mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
10.1.3 North Africa mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
10.1.4 South Africa mRNA Vaccines & Therapeutics Market Volume and Growth Rate
-
10.1.5 Argentina mRNA Vaccines & Therapeutics Market Volume and Growth Rate
11 Major Players Profiles
-
11.1 PhaseRx
-
11.1.1 PhaseRx Company Profile and Development Status
-
11.1.2 Market Performance
-
11.1.3 Product and Service Introduction
-
11.2 MaxCyte
-
11.2.1 MaxCyte Company Profile and Development Status
-
11.2.2 Market Performance
-
11.2.3 Product and Service Introduction
-
11.3 CureVac
-
11.3.1 CureVac Company Profile and Development Status
-
11.3.2 Market Performance
-
11.3.3 Product and Service Introduction
-
11.4 AstraZeneca
-
11.4.1 AstraZeneca Company Profile and Development Status
-
11.4.2 Market Performance
-
11.4.3 Product and Service Introduction
-
11.5 Bayer
-
11.5.1 Bayer Company Profile and Development Status
-
11.5.2 Market Performance
-
11.5.3 Product and Service Introduction
-
11.6 BioNTech
-
11.6.1 BioNTech Company Profile and Development Status
-
11.6.2 Market Performance
-
11.6.3 Product and Service Introduction
-
11.7 RaNa Therapeutics
-
11.7.1 RaNa Therapeutics Company Profile and Development Status
-
11.7.2 Market Performance
-
11.7.3 Product and Service Introduction
-
11.8 Moderna Therapeutics
-
11.8.1 Moderna Therapeutics Company Profile and Development Status
-
11.8.2 Market Performance
-
11.8.3 Product and Service Introduction
-
11.9 Precision NanoSystems
-
11.9.1 Precision NanoSystems Company Profile and Development Status
-
11.9.2 Market Performance
-
11.9.3 Product and Service Introduction
-
11.10 Argos Therapeutics
-
11.10.1 Argos Therapeutics Company Profile and Development Status
-
11.10.2 Market Performance
-
11.10.3 Product and Service Introduction
-
11.11 Novartis
-
11.11.1 Novartis Company Profile and Development Status
-
11.11.2 Market Performance
-
11.11.3 Product and Service Introduction
-
11.12 GlaxoSmithKline Vaccines
-
11.12.1 GlaxoSmithKline Vaccines Company Profile and Development Status
-
11.12.2 Market Performance
-
11.12.3 Product and Service Introduction
-
11.13 Kernal Biologics
-
11.13.1 Kernal Biologics Company Profile and Development Status
-
11.13.2 Market Performance
-
11.13.3 Product and Service Introduction
-
11.14 In-Cell-Art
-
11.14.1 In-Cell-Art Company Profile and Development Status
-
11.14.2 Market Performance
-
11.14.3 Product and Service Introduction
-
11.15 Janssen
-
11.15.1 Janssen Company Profile and Development Status
-
11.15.2 Market Performance
-
11.15.3 Product and Service Introduction
-
11.16 Intellia Therapeutics
-
11.16.1 Intellia Therapeutics Company Profile and Development Status
-
11.16.2 Market Performance
-
11.16.3 Product and Service Introduction
-
11.17 CRISPR Therapeutics
-
11.17.1 CRISPR Therapeutics Company Profile and Development Status
-
11.17.2 Market Performance
-
11.17.3 Product and Service Introduction
-
11.18 eTheRNA immunotherapies
-
11.18.1 eTheRNA immunotherapies Company Profile and Development Status
-
11.18.2 Market Performance
-
11.18.3 Product and Service Introduction
-
11.19 Boehringer Ingelheim
-
11.19.1 Boehringer Ingelheim Company Profile and Development Status
-
11.19.2 Market Performance
-
11.19.3 Product and Service Introduction
-
11.20 Ethris
-
11.20.1 Ethris Company Profile and Development Status
-
11.20.2 Market Performance
-
11.20.3 Product and Service Introduction
The List of Tables and Figures (Totals 104 Figures and 208 Tables)
-
Figure Product Picture
-
Figure mRNA Vaccines & Therapeutics Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine from 2014 to 2026
-
Figure mRNA Vaccines & Therapeutics Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine from 2014 to 2026
-
Figure mRNA Vaccines & Therapeutics Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine from 2014 to 2026
-
Figure mRNA Vaccines & Therapeutics Market Size and Growth Rate of Infection Prevention MRNA Vaccine from 2014 to 2026
-
Figure Global mRNA Vaccines & Therapeutics Market Size and Growth Rate of Hospital from 2014 to 2026
-
Figure Global mRNA Vaccines & Therapeutics Market Size and Growth Rate of Clinic from 2014 to 2026
-
Figure Global mRNA Vaccines & Therapeutics Market Size and Growth Rate of Others from 2014 to 2026
-
Figure North America mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure United States mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure Canada mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure Mexico mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure Germany mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure UK mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure France mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure Italy mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure Nordic mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure Spain mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure Belgium mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure Poland mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure Russia mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure Turkey mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure Asia-Pacific mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure China mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure Japan mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure Australia mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure India mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure ASEAN mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure South Korea mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure LAMEA mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure GCC mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure Brazil mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure North Africa mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure South Africa mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure Argentina mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of mRNA Vaccines & Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of mRNA Vaccines & Therapeutics
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of mRNA Vaccines & Therapeutics by Different Types from 2014 to 2026
-
Table Consumption Share of mRNA Vaccines & Therapeutics by Different Types from 2014 to 2026
-
Figure Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine
-
Figure Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine
-
Figure Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine
-
Figure Market Size and Growth Rate of Infection Prevention MRNA Vaccine
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of mRNA Vaccines & Therapeutics by Different End-Users from 2014 to 2026
-
Table Consumption Share of mRNA Vaccines & Therapeutics by Different End-Users from 2014 to 2026
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Clinic
-
Figure Market Size and Growth Rate of Others
-
Table Global mRNA Vaccines & Therapeutics Production by Major Regions
-
Table Global mRNA Vaccines & Therapeutics Production Share by Major Regions
-
Table Global mRNA Vaccines & Therapeutics Consumption by Major Regions
-
Table Global mRNA Vaccines & Therapeutics Consumption Share by Major Regions
-
Table North America mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis
-
Table Europe mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis
-
Table Asia Pacific mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis
-
Table LAMEA mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis
-
Table Top 5 Export Countries' Export Value Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019
-
Table Top 5 Export Countries' Export Volume Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019
-
Table Top 5 Import Countries' Import Value Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019
-
Table Top 5 Import Countries' Import Volume Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019
-
Figure Emerging Top 3 Export Countries Analysis
-
Figure Emerging Top 3 Import Countries Analysis
-
Table North America mRNA Vaccines & Therapeutics Consumption by Major Countries from 2014 to 2026
-
Table North America mRNA Vaccines & Therapeutics Consumption Share by Major Countries from 2014 to 2026
-
Figure North America mRNA Vaccines & Therapeutics Consumption Share by Major Countries in 2014
-
Figure North America mRNA Vaccines & Therapeutics Consumption Share by Major Countries in 2018
-
Figure North America mRNA Vaccines & Therapeutics Consumption Share by Major Countries in 2026
-
Figure United States mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Canada mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Mexico mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Table Europe mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026
-
Table Europe mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026
-
Table Europe mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Europe mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Table Europe mRNA Vaccines & Therapeutics Consumption by Major Countries from 2014 to 2026
-
Table Europe mRNA Vaccines & Therapeutics Consumption Share by Major Countries from 2014 to 2026
-
Figure Germany mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure UK mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure France mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Italy mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Nordic mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Spain mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Belgium mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Poland mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Russia mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Turkey mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Netherlands mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Portugal mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Denmark mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Finland mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Iceland mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Norway mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Sweden mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Table Asia Pacific mRNA Vaccines & Therapeutics Consumption by Major Countries from 2014 to 2026
-
Table Asia Pacific mRNA Vaccines & Therapeutics Consumption Share by Major Countries from 2014 to 2026
-
Figure China mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Japan mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Australia mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure India mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure ASEAN mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure South Korea mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Table Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Major Countries from 2014 to 2026
-
Table Latin America, Middle East & Africa mRNA Vaccines & Therapeutics Consumption Share by Major Countries from 2014 to 2026
-
Figure GCC Countries mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Brazil Countries mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure North Africa Countries mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure South Africa Countries mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Argentina Countries mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Table Company Profile and Development Status of PhaseRx
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of PhaseRx
-
Figure Sales and Growth Rate Analysis of PhaseRx
-
Figure Revenue and Market Share Analysis of PhaseRx
-
Table Product and Service Introduction of PhaseRx
-
-
Table Company Profile and Development Status of MaxCyte
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of MaxCyte
-
Figure Sales and Growth Rate Analysis of MaxCyte
-
Figure Revenue and Market Share Analysis of MaxCyte
-
Table Product and Service Introduction of MaxCyte
-
Table Company Profile and Development Status of CureVac
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CureVac
-
Figure Sales and Growth Rate Analysis of CureVac
-
Figure Revenue and Market Share Analysis of CureVac
-
Table Product and Service Introduction of CureVac
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of BioNTech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioNTech
-
Figure Sales and Growth Rate Analysis of BioNTech
-
Figure Revenue and Market Share Analysis of BioNTech
-
Table Product and Service Introduction of BioNTech
-
Table Company Profile and Development Status of RaNa Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of RaNa Therapeutics
-
Figure Sales and Growth Rate Analysis of RaNa Therapeutics
-
Figure Revenue and Market Share Analysis of RaNa Therapeutics
-
Table Product and Service Introduction of RaNa Therapeutics
-
Table Company Profile and Development Status of Moderna Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Moderna Therapeutics
-
Figure Sales and Growth Rate Analysis of Moderna Therapeutics
-
Figure Revenue and Market Share Analysis of Moderna Therapeutics
-
Table Product and Service Introduction of Moderna Therapeutics
-
Table Company Profile and Development Status of Precision NanoSystems
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Precision NanoSystems
-
Figure Sales and Growth Rate Analysis of Precision NanoSystems
-
Figure Revenue and Market Share Analysis of Precision NanoSystems
-
Table Product and Service Introduction of Precision NanoSystems
-
Table Company Profile and Development Status of Argos Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Argos Therapeutics
-
Figure Sales and Growth Rate Analysis of Argos Therapeutics
-
Figure Revenue and Market Share Analysis of Argos Therapeutics
-
Table Product and Service Introduction of Argos Therapeutics
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of GlaxoSmithKline Vaccines
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Vaccines
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline Vaccines
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline Vaccines
-
Table Product and Service Introduction of GlaxoSmithKline Vaccines
-
Table Company Profile and Development Status of Kernal Biologics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kernal Biologics
-
Figure Sales and Growth Rate Analysis of Kernal Biologics
-
Figure Revenue and Market Share Analysis of Kernal Biologics
-
Table Product and Service Introduction of Kernal Biologics
-
Table Company Profile and Development Status of In-Cell-Art
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of In-Cell-Art
-
Figure Sales and Growth Rate Analysis of In-Cell-Art
-
Figure Revenue and Market Share Analysis of In-Cell-Art
-
Table Product and Service Introduction of In-Cell-Art
-
Table Company Profile and Development Status of Janssen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen
-
Figure Sales and Growth Rate Analysis of Janssen
-
Figure Revenue and Market Share Analysis of Janssen
-
Table Product and Service Introduction of Janssen
-
Table Company Profile and Development Status of Intellia Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Intellia Therapeutics
-
Figure Sales and Growth Rate Analysis of Intellia Therapeutics
-
Figure Revenue and Market Share Analysis of Intellia Therapeutics
-
Table Product and Service Introduction of Intellia Therapeutics
-
Table Company Profile and Development Status of CRISPR Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CRISPR Therapeutics
-
Figure Sales and Growth Rate Analysis of CRISPR Therapeutics
-
Figure Revenue and Market Share Analysis of CRISPR Therapeutics
-
Table Product and Service Introduction of CRISPR Therapeutics
-
Table Company Profile and Development Status of eTheRNA immunotherapies
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of eTheRNA immunotherapies
-
Figure Sales and Growth Rate Analysis of eTheRNA immunotherapies
-
Figure Revenue and Market Share Analysis of eTheRNA immunotherapies
-
Table Product and Service Introduction of eTheRNA immunotherapies
-
Table Company Profile and Development Status of Boehringer Ingelheim
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim
-
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim
-
Figure Revenue and Market Share Analysis of Boehringer Ingelheim
-
Table Product and Service Introduction of Boehringer Ingelheim
-
Table Company Profile and Development Status of Ethris
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ethris
-
Figure Sales and Growth Rate Analysis of Ethris
-
Figure Revenue and Market Share Analysis of Ethris
-
Table Product and Service Introduction of Ethris
